Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

ClinicalTrials.gov ID: NCT02974647

Public ClinicalTrials.gov record NCT02974647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Multicenter Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Study identification

NCT ID: NCT02974647
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Enrollment: 83 participants

Conditions and interventions

Conditions

Lymphoma

Interventions

Ruxolitinib Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2016
Primary completion: Oct 31, 2027
Completion: Oct 31, 2027
Last update posted: Apr 21, 2026

2016 – 2027

United States locations

U.S. sites: 10
U.S. states: 5
U.S. cities: 9

Facility	City	State	ZIP	Site status
University of Miami	Miami	Florida	—	Active, not recruiting
Northwestern Medicine (Data collection and specimen analysis)	Chicago	Illinois	60611	Active, not recruiting
Dana Farber Cancer Institute	Boston	Massachusetts	02115	Active, not recruiting
Memorial Sloan Kettering Basking Ridge	Basking Ridge	New Jersey	07920	Recruiting
Memorial Sloan Kettering Monmouth (All Protocol Activities)	Middletown	New Jersey	07748	Recruiting
Memorial Sloan Kettering Commack	Commack	New York	11725	Recruiting
Memorial Sloan Kettering Westchester	Harrison	New York	10604	Recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
Weill Cornell Medical College	New York	New York	—	Active, not recruiting
Memorial Sloan Kettering Nassau (All Protocol Activities)	Uniondale	New York	11553	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02974647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 21, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02974647 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →